These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 99596)

  • 1. [Pharmacotherapy of peripheral arteriosclerosis].
    Belousov IuB; Savenkov PM; Sidel'man AA; Parfenov AS; Savenkov MP
    Kardiologiia; 1978 Aug; 18(8):36-43. PubMed ID: 99596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of occlusive atherosclerosis. Long-term administration of pyridinol carbamate.
    Redisch W; Clauss RH; Rouen LR; Katz MC; Terry EN
    Arch Surg; 1975 Mar; 110(3):258-61. PubMed ID: 803830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].
    Liusov VA; Belousov IuB; Martynov AI; Koroleva SA; Zimin VS
    Kardiologiia; 1972 Nov; 12(11):39-45. PubMed ID: 4655879
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of pyridinol carbamate (Anginin) in peripheral arterial blood circulation disorders].
    Heisig N; Westermann KW; Stolterfoht CA; Zaki J
    Med Klin; 1970 Dec; 65(52):2289-93. PubMed ID: 5522670
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L; Boeri S; Ricci G
    Minerva Cardioangiol; 1974; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological action on the thrombocyte link in hemostasis in the treatment of ischemic heart disease].
    Komarov FI; Liusov VA; Bokarev IN
    Kardiologiia; 1978 Mar; 18(3):12-8. PubMed ID: 347133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pyridinolcarbamate after acute and chronic administration in patients with atherosclerosis obliterans.
    Roztocil K; Oliva J; Linhart J; Prerovský I; Modr Z
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):135-8. PubMed ID: 844932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
    Cavaller JM; Samper JC
    Med Monatsschr; 1976 Jul; 30(7):323-6. PubMed ID: 790140
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of pentoxifylline and of bio-electromagnetic therapy in lower limb obliterative arterial disease].
    Bernát SI
    Orv Hetil; 2013 Oct; 154(42):1674-9. PubMed ID: 24121220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
    Beykirch H; Reuter W; Voigt H; Herrmann W
    Z Gesamte Inn Med; 1989 Feb; 44(3):77-9. PubMed ID: 2728555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of treatment with trental on indicators of peripheral hemodynamics and blood lipid level in patients with arteriosclerosis of the lower extremities].
    Sidorenko GI; Tsapaev VG; Tsapaeva NL; Atroshchenko ES
    Kardiologiia; 1987 Nov; 27(11):77-80. PubMed ID: 3437669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research on the activity of propaxoline in vasculopathic syndromes. II. Peripheral rheographic studies of the lower extremities].
    Rottini E; Martinelli M; Capitanucci P; De Gregorio M
    Boll Soc Ital Biol Sper; 1967 Aug; 43(16):970-2. PubMed ID: 6073457
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of fluvastain and its combination with aspirin and trental on hemostasis and microcirculation in atherosclerosis].
    Zhdanova IV; Tsvirenko SV; Barats SS; Smolenskaia OG; Volkova RF; Serezhenko TO
    Ter Arkh; 2002; 74(8):9-12. PubMed ID: 12360609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial results of pentoxifylline ('Trental') therapy in arteriosclerosis obliterans: possible mechanism of action.
    Kostka-Trabkowa E; Dembińska-Kieć A; Grodzińska L; Bieroń K; Gryglewski RJ
    Curr Med Res Opin; 1985; 9(6):407-15. PubMed ID: 3886306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
    Kuczyńska K; Zebrowski M; Kancelarczyk WL; Rymaszewski Z
    Pol Tyg Lek; 1988 Aug; 43(34):1092-4. PubMed ID: 3075031
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A; Borri P; Parravicini R
    Minerva Cardioangiol; 1975 Nov; 23(11):701-10. PubMed ID: 1223674
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the action of p-chlorophenoxy alpha-isobutyrate of 3-hydroxymethyl pyridine hydrochloride on peripheral circulation. Rheographic and radioisotope studies].
    Modica G; Ferrante R
    Minerva Cardioangiol; 1973 Dec; 21(12):769-74. PubMed ID: 4592148
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
    Vogralik VG; Vogralik MV; Runov GP; Runova AA; Kostrov AI
    Klin Med (Mosk); 1982 Oct; 60(10):90-4. PubMed ID: 7176484
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
    Majkowski J; Lysakowska-Sernicka K; Gajewska A; Bilińska-Nigot B; Ostrowski K; Semenicki K
    Neurol Neurochir Pol; 1978; 12(4):387-96. PubMed ID: 714218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.